Table 1.
Baseline demographic and clinical characteristics.
| This Cohort (n=46) | |
|---|---|
| Age, year median (IQR) | 54.0 (46.3-59.0) |
| Sex | |
| male | 23 (50.0%) |
| female | 23 (50.0%) |
| Etiology | |
| HBV | 20 (43.5%) |
| Other | 26 (56.5%) |
| ECOG | |
| 0 | 34 (73.9%) |
| 1 | 12 (26.1%) |
| Child Pugh score | |
| A5 | 32 (69.6%) |
| A6 | 14 (30.4%) |
| Cirrhosis | |
| Yes | 11 (23.9%) |
| No | 35 (76.1%) |
| TNM stage at baseline | |
| IIIA | 9 (19.6%) |
| IIIB | 22 (47.8%) |
| IV | 15 (32.6%) |
| Tumor diameter, cm | |
| Mean ± SD | 10.1 ± 3.3 |
| Median (IQR) | 9.4 (7.5-12.8) |
| Tumor number | |
| 1-3 | 5 (10.9%) |
| >3 | 41 (89.1%) |
| Vascular Invasion | |
| Absent | 25 (54.3%) |
| Present | 21 (45.7%) |
| Extrahepatic Metastasis | |
| Absent | 9 (19.6%) |
| Present | 37 (80.4%) |
| Lymph nodes only | 22 (47.8%) |
| Organ only | 1 (2.2%) |
| Organ plus lymph nodes | 14 (30.4%) |
| CA19-9 level, Median (IQR), U/mL | 134.7 (36.7-748.5) |
| ≤ 35 | 11 (23.9%) |
| > 35 | 35 (76.1%) |
| CEA level, Median (IQR), ng/mL | 3.8 (2.3-13.7) |
| ≤ 5 | 28 (60.9%) |
| > 5 | 18 (39.1%) |